Saxagliptin + saxagliptin/metformin (Addendum to Commission A16-42 + A16-43)

Report documents

1. Addendum

   Saxagliptin + saxagliptin/metformin (Addendum to Commission A16-42 + A16-43)

   published on

   20.12.2016

   Document type

   PDF-Dokument, 188 kB, EN, PDF

   Download file : Addendum (PDF-Dokument, 188 kB, EN, PDF)

Additional information

Project details

Project no.

A16-71

Commission

Commission awarded on 07.11.2016 by the Federal Joint Committee (GBA).

Report type

Addendum

Status

Commission completed

Department/Division

Drug Assessment

Topic

Digestion, metabolism and hormones

Note

If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.

Connected Projects

1. Dossier assessment

   Saxagliptin/metformin - Benefit assessment according to §35a Social Code Book V

   Project no.

   A16-43

   Last updated

   15.12.2016

   Status: Commission completed

2. Dossier assessment

   Saxagliptin - Benefit assessment according to §35a Social Code Book V

   Project no.

   A16-42

   Last updated

   15.12.2016

   Status: Commission completed